Conclusions After 10 years of randomised treatment, women receiving hormone replacement therapy early after menopause had a significantly reduced risk of mortality, heart failure, or myocardial infarction, without any apparent increase in risk of cancer, venous thromboembolism, or stroke.They used bio-identicals you see, not cheaper, artificial estrogen-like compounds as with other studies.
Friday, 1 March 2013
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial | BMJ
Effect of hormone replacement therapy on cardiovascular events in recently postmenopausal women: randomised trial Schierbeck et al BMJ 2012;345:e6409
Subscribe to:
Post Comments (Atom)
2 comments:
Hi Zoe, Thanks or this link. Being an alternative/holistic medicine physician I can only prescribe bioidentical hormones. The US FDA and other agencies are trying hard to push the synthetics. It is
about $ and what is patentable and they do not care what happens to the patients. I think that the synthetic hormones are dangerous and I do not recommend them. Every hormone that you can think of is available as a bioidentical hormone
and can be made just as potent.
Post a Comment